First human test of stem cells to fight frailty and aging weakness
Disease control
Not yet recruiting
This is a very early safety study testing an experimental stem cell treatment called HeXell-2020 in older adults with mild to moderate frailty. The main goal is to find a safe dose and check for side effects in up to 12 participants aged 60-85. Researchers will also look for earl…
Phase: PHASE1 • Sponsor: Hexun Biosciences Co., LTD. • Aim: Disease control
Last updated Feb 18, 2026 14:07 UTC